Table 4.
Proportion of mRS 0–1 points
| Group | N | Proportion of the mRS score of 0–1, n (%) | ||
|---|---|---|---|---|
| 14 days | 30 days | 90 days | ||
| Treatment group (n = 69) | 69 | 24 (34.78%) | 36 (52.17%) | 44 (63.77%) |
| Control group (n = 73) | 73 | 15 (20.55%) | 20 (27.40%) | 37 (50.68%) |
| P value | / | 0.008 | 0.004 | 0.012 |
| Thrombolysis group (n = 24) | 24 | 7 (29.17%) | 12 (50.00%) | 15 (62.50%) |
| Thrombolysis control group (n = 21) | 21 | 7 (33.33%) | 10 (47.62%) | 10 (47.62%) |
| P value | / | 0.687 | 0.695 | 0.015 |
| Thrombectomy treatment group (n = 39) | 39 | 12 (30.77%) | 19 (48.72%) | 24 (61.54%) |
| Thrombectomy control group (n = 40) | 40 | 12 (30.00%) | 19 (47.50%) | 18 (45.00%) |
| P value | / | 0.923 | 0.854 | 0.026 |